Satellos Bioscience, Inc. (MSLE)
6.86
+0.51
(+8.03%)
USD |
NASDAQ |
Nov 06, 10:16
Satellos Bioscience Total Assets (Quarterly) : 65.77M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 65.77M |
| March 31, 2026 | 75.23M |
| December 31, 2025 | 31.89M |
| September 30, 2025 | 37.50M |
| June 30, 2025 | 41.12M |
| March 31, 2025 | 44.37M |
| December 31, 2024 | 50.77M |
| September 30, 2024 | 17.92M |
| June 30, 2024 | 24.26M |
| March 31, 2024 | 28.27M |
| December 31, 2023 | 33.59M |
| September 30, 2023 | 36.00M |
| June 30, 2023 | 40.11M |
| March 31, 2023 | 5.208M |
| December 31, 2022 | 4.575M |
| September 30, 2022 | 7.440M |
| June 30, 2022 | 7.051M |
| March 31, 2022 | 8.322M |
| December 31, 2021 | 9.964M |
| September 30, 2021 | 11.36M |
| June 30, 2021 | 7.394M |
| March 31, 2021 | 1.739M |
| December 31, 2020 | 0.8865M |
| September 30, 2020 | 0.4768M |
| June 30, 2020 | 0.6232M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.8352M |
| December 31, 2019 | 1.132M |
| September 30, 2019 | 1.332M |
| June 30, 2019 | 0.2826M |
| March 31, 2019 | 0.7611M |
| December 31, 2018 | 0.1305M |
| September 30, 2018 | 0.1863M |
| June 30, 2018 | 0.738M |
| March 31, 2018 | 0.6847M |
| December 31, 2017 | 1.098M |
| September 30, 2017 | 1.180M |
| June 30, 2017 | 1.320M |
| March 31, 2017 | 1.650M |
| December 31, 2016 | 1.828M |
| September 30, 2016 | 2.044M |
| June 30, 2016 | 2.189M |
| March 31, 2016 | 2.316M |
| December 31, 2015 | 2.805M |
| September 30, 2015 | 3.354M |
| June 30, 2015 | 3.751M |
| March 31, 2015 | 4.965M |
| December 31, 2014 | 6.114M |
| September 30, 2014 | 7.719M |
| June 30, 2014 | 8.113M |
| March 31, 2014 | 10.50M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Xenon Pharmaceuticals, Inc. | 1.296B |
| Psyence Biomedical Ltd. | 12.81M |
| Aurinia Pharmaceuticals, Inc. | 825.70M |
| enGene Therapeutics, Inc. | 288.32M |
| Medicus Pharma Ltd. | 19.11M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 5.861M |
| Shareholders Equity (Quarterly) | 59.91M |
| Current Ratio | 11.22 |